NPM1-mutant Refractory or Relapsed AML
1 clinical trials · Condition
◉ Watch NPM1-mutant Refractory or Relapsed AML
| Record | Firm | Date |
|---|---|---|
| Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML (NCT07355335) | Massachusetts General Hospital | 2026-07-09 |
Track NPM1-mutant Refractory or Relapsed AML automatically
Every clearance here is in the API, with alerts when new ones post.